相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease
Joshua D. Crapser et al.
BRAIN (2020)
Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects
Jolene Ooi et al.
CELL REPORTS (2019)
Chromosomal instability during neurogenesis in Huntington's disease
Albert Ruzo et al.
DEVELOPMENT (2018)
Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes
P. Conforti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease
Swati Naphade et al.
FRONTIERS IN NEUROSCIENCE (2018)
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
Lauren M. Byrne et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis
Pablo Garcia-Reitboeck et al.
CELL REPORTS (2018)
Taming Human Genetic Variability: Transcriptomic Meta-Analysis Guides the Experimental Design and Interpretation of iPSC-Based Disease Modeling
Pierre-Luc Germain et al.
STEM CELL REPORTS (2017)
A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response
Walther Haenseler et al.
STEM CELL REPORTS (2017)
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
Xiaohong Xu et al.
STEM CELL REPORTS (2017)
Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells
James R. C. Miller et al.
SCIENTIFIC REPORTS (2017)
Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis
Ralph Andre et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
RNA-Seq of Huntington's disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation
James R. C. Miller et al.
HUMAN MOLECULAR GENETICS (2016)
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
Lucianne Dobson et al.
JOURNAL OF NEUROCHEMISTRY (2016)
ENHANCED IMMUNE RESPONSE TO MMP3 STIMULATION IN MICROGLIA EXPRESSING MUTANT HUNTINGTIN
C. Connolly et al.
NEUROSCIENCE (2016)
Genetic Variation, Not Cell Type of Origin, Underlies the Majority of Identifiable Regulatory Differences in iPSCs
Courtney K. Burrows et al.
PLOS GENETICS (2016)
Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential
Aija Kyttala et al.
STEM CELL REPORTS (2016)
Plasma inflammatory biomarkers for Huntington's disease patients and mouse model
Kuo-Hsuan Chang et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Activin A directs striatal projection neuron differentiation of human pluripotent stem cells
Charles Arber et al.
DEVELOPMENT (2015)
HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity
Virginia B. Mattis et al.
HUMAN MOLECULAR GENETICS (2015)
Treating the whole body in Huntington's disease
Jeffrey B. Carroll et al.
LANCET NEUROLOGY (2015)
Huntingtin functions as a scaffold for selective macroautophagy
Yan-Ning Rui et al.
NATURE CELL BIOLOGY (2015)
Huntington disease
Gillian P. Bates et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation
Ulrike Traeger et al.
BRAIN (2014)
The Role of Oxidative Stress in Huntington's Disease: Are Antioxidants Good Therapeutic Candidates?
Joana Gil-Mohapel et al.
CURRENT DRUG TARGETS (2014)
Mutations of the Huntington's Disease Protein Impact on the ATM-Dependent Signaling and Repair Pathways of the Radiation-Induced DNA Double-Strand Breaks: Corrective Effect of Statins and Bisphosphonates
Melanie L. Ferlazzo et al.
MOLECULAR NEUROBIOLOGY (2014)
Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors
Andrea Crotti et al.
NATURE NEUROSCIENCE (2014)
Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
Foad Rouhani et al.
PLOS GENETICS (2014)
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2013)
Efficient, Long Term Production of Monocyte-Derived Macrophages from Human Pluripotent Stem Cells under Partly-Defined and Fully-Defined Conditions
Bonnie van Wilgenburg et al.
PLOS ONE (2013)
Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
CELL STEM CELL (2012)
Genetic Correction of Huntington's Disease Phenotypes in Induced Pluripotent Stem Cells
Mahru C. An et al.
CELL STEM CELL (2012)
Dithiol-based Compounds Maintain Expression of Antioxidant Protein Peroxiredoxin 1 That Counteracts Toxicity of Mutant Huntingtin
Andrea Pitts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Mutant huntingtin impairs immune cell migration in Huntington disease
Wanda Kwan et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
Andreas Weiss et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease
Wanda Kwan et al.
JOURNAL OF NEUROSCIENCE (2012)
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease
Jill Bouchard et al.
JOURNAL OF NEUROSCIENCE (2012)
Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons
Andrew D. Kraft et al.
NEUROBIOLOGY OF AGING (2012)
Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease
Sonia Franciosi et al.
NEUROBIOLOGY OF DISEASE (2012)
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
Stefano Camnasio et al.
NEUROBIOLOGY OF DISEASE (2012)
Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice
Junghee Lee et al.
ACTA NEUROPATHOLOGICA (2011)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
Microglial activation in regions related to cognitive function predicts disease onset in Huntington's Disease: A multimodal imaging study
Marios Politis et al.
HUMAN BRAIN MAPPING (2011)
Sterile inflammation: sensing and reacting to damage
Grace Y. Chen et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Javier Palazuelos et al.
BRAIN (2009)
Cannabinoid CB2 Receptor Agonists Protect the Striatum Against Malonate Toxicity: Relevance for Huntington's Disease
Onintza Sagredo et al.
GLIA (2009)
Evidence of Oxidant Damage in Huntington's Disease: Translational Strategies Using Antioxidants
Edward C. Stack et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Maria Bjorkqvist et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Microglial activation in presymptomatic Huntington's disease gene carriers
Yen F. Tai et al.
BRAIN (2007)
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
Annette Dalrymple et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Oxidative damage in Huntington's disease pathogenesis
Susan E. Browne et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Microglial activation correlates with severity in Huntington disease - A clinical and PET study
N. Pavese et al.
NEUROLOGY (2006)
Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington's disease mutation
F Pérez-Severiano et al.
NEUROCHEMICAL RESEARCH (2004)
Molecular consequences of activated microglia in the brain: overactivation induces apoptosis
B Liu et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Early and progressive accumulation of reactive microglia in the Huntington disease brain
E Sapp et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
分享论文
